Body Mass Index and Smoking Affect Thioguanine Nucleotide Levels in Inflammatory Bowel Disease
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Body Mass Index and Smoking Affect Thioguanine Nucleotide Levels in Inflammatory Bowel Disease
Authors
Keywords
-
Journal
Journal of Crohns & Colitis
Volume 9, Issue 8, Pages 640-646
Publisher
Oxford University Press (OUP)
Online
2015-05-13
DOI
10.1093/ecco-jcc/jjv084
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association Between 6-Thioguanine Nucleotides Levels and Clinical Remission in Inflammatory Disease
- (2014) Amelie Carla Moreau et al. INFLAMMATORY BOWEL DISEASES
- Body Mass Index and the Risk for Crohn's Disease and Ulcerative Colitis: Data From a European Prospective Cohort Study (The IBD in EPIC Study)
- (2013) Simon S M Chan et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Does weight-adjusted anti-tumour necrosis factor treatment favour obese patients with Crohn’s disease?
- (2013) Mahesh Bhalme et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Early Administration of Azathioprine vs Conventional Management of Crohn's Disease: A Randomized Controlled Trial
- (2013) Jacques Cosnes et al. GASTROENTEROLOGY
- Early Azathioprine Therapy Is No More Effective Than Placebo for Newly Diagnosed Crohn's Disease
- (2013) Julián Panés et al. GASTROENTEROLOGY
- Increased Body Mass Index Is Associated with Earlier Time to Loss of Response to Infliximab in Patients with Inflammatory Bowel Disease
- (2013) Jason W. Harper et al. INFLAMMATORY BOWEL DISEASES
- Does obesity complicate inflammatory bowel diseases?
- (2012) Ana Tieko Meyer Nascimento et al. Journal of Crohns & Colitis
- Predictors of dose escalation of adalimumab in a prospective cohort of Crohn’s disease patients
- (2011) E. Bultman et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Clinical Usefulness of a New Equation for Estimating Body Fat
- (2011) J. Gomez-Ambrosi et al. DIABETES CARE
- Identification of an imprinted master trans regulator at the KLF14 locus related to multiple metabolic phenotypes
- (2011) Kerrin S Small et al. NATURE GENETICS
- Low-dose azathioprine or mercaptopurine in combination with allopurinol can bypass many adverse drug reactions in patients with inflammatory bowel disease
- (2010) A. ANSARI et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Effect of Obesity on the Pharmacokinetics of Drugs in Humans
- (2010) Michael J. Hanley et al. CLINICAL PHARMACOKINETICS
- Smoking status and response to thiopurines in steroid-dependent inflammatory bowel disease
- (2010) Eugeni Domènech et al. INFLAMMATORY BOWEL DISEASES
- Prevalence and epidemiology of overweight and obesity in children with inflammatory bowel disease 12
- (2010) Millie D. Long et al. INFLAMMATORY BOWEL DISEASES
- A Brief Report of the Epidemiology of Obesity in the Inflammatory Bowel Disease Population of Tayside, Scotland
- (2010) Helen Steed et al. Obesity Facts
- Meta-analysis: the efficacy of azathioprine and mercaptopurine in ulcerative colitis
- (2009) J. P. GISBERT et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Significant Differences Between Crohn’s Disease and Ulcerative Colitis Regarding the Impact of Body Mass Index and Initial Disease Activity on Responsiveness to Azathioprine: Results from a European Multicenter Study in 1,176 Patients
- (2009) Martin H. Holtmann et al. DIGESTIVE DISEASES AND SCIENCES
- Thiopurine Dose in Intermediate and Normal Metabolizers of Thiopurine Methyltransferase May Differ Three-Fold
- (2008) Sharon J. Gardiner et al. Clinical Gastroenterology and Hepatology
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now